The effectiveness of a population-based skin cancer screening program: evidence from Germany
Tóm tắt
In this paper, we analyze how a nationwide population-based skin cancer screening program (SCS) implemented in Germany in 2008 has impacted the number of hospital discharges following malignant skin neoplasm diagnosis and the malignant melanoma mortality rate per 100,000 inhabitants. Our panel data, drawn from the Eurostat database, cover subregions in 22 European countries, measured at the lowest nomenclature of territorial units for statistics (NUTS) level for 2000–2013. Applying fixed effects methods, we find a significantly positive and robust effect of the German SCS on the number of patients diagnosed with malignant skin neoplasm. However, the program does not significantly influence the melanoma mortality rate. This finding conflicts with the decreased melanoma mortality rate found for the pilot SCS program in northern Germany. Our results indicate that Germany’s nationwide SCS program is effective in terms of a higher diagnosis rate for malignant skin neoplasms and thus may contribute to an improvement in the early detection of skin cancer.
Tài liệu tham khảo
World Health Organization: Skin cancers. How common is skin cancer? http://www.who.int/uv/faq/skincancer/en/index1.html (2016) Accessed 4 May 2016
American Cancer Society: Cancer facts & figures 2017. American Cancer Society, Atlanta (2017)
MacKie, R.M., Hauschild, A., Eggermont, A.M.M.: Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20, 7 (2009)
Robert Koch Institut und die Gesellschaft für der epidemiologischen Krebsregister in Deutschland e. V.: Krebs in Deutschland 2011/2012 (2015). http://www.gekid.de/Doc/krebs_in_deutschland_2015.pdf. Accessed 4 May 2016
Breitbart, E.W., Waldmann, A., Nolte, S., Capellaro, M., Greinert, R., Volkmer, B., Katalinic, A.: Systematic skin cancer screening in northern Germany. J. Am. Acad. Dermatol. 66(2), 201–211 (2012)
Choudhury, K., Volkmer, B., Greinert, R., Christophers, E., Breitbart, E.W.: Effectiveness of skin cancer screening programmes. Br. J. Dermatol. 167, 94–98 (2012)
Eisemann, N., Waldmann, A., Garbe, C., Katalinic, A.: Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Med. Decis. Making 35(2), 243–254 (2015)
Stang, A., Garbe, C., Autier, P., Jöckel, K.-H., Autier, P., Jockel, K.-H.: The many unanswered questions related to the German skin cancer screening programme. Eur. J. Cancer 64, 83–88 (2016)
Geller, A.C., Greinert, R., Sinclair, C., Weinstock, M.A., Aitken, J., Boniol, M., Capellaro, M., Doré, J.-F., Elwood, M., Fletcher, S.W., Gallagher, R., Gandini, S., Halpern, A.C., Katalinic, A., Lucas, R., Marghoob, A.A., Nolte, S., Schüz, J., Tucker, M.A., Volkmer, B., Breitbart, E.: A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol. 34(3), 355–358 (2010)
Veit, C., Lüken, F., Melsheimer, O.: Evaluation der Screeninguntersuchungen auf Hautkrebs gemäß Krebsfrüherkennungs-Richtlinie des Gemeinsamen Bundesausschusses. Abschlussbericht 2009–2010 (2015). https://www.g-ba.de/downloads/17-98-3907/2015-03-11_BQS_HKS-Abschlussbericht-2009-2010.pdf. Accessed 4 May 2016.
Katalinic, A., Waldmann, A., Weinstock, M.A., Geller, A.C., Eisemann, N., Greinert, R., Volkmer, B., Breitbart, E.: Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 118(21), 5395–5402 (2012)
Waldmann, A., Nolte, S., Weinstock, M.A., Breitbart, E.W., Eisemann, N., Geller, A.C., Greinert, R., Volkmer, B., Katalinic, A.: Skin cancer screening participation and impact on melanoma incidence in Germany—an observational study on incidence trends in regions with and without population-based screening. Br. J. Cancer 106(5), 970–974 (2012)
Eisemann, N., Waldmann, A., Geller, A.C., Weinstock, M.A., Volkmer, B., Greinert, R., Breitbart, E.W., Katalinic, A.: Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol 134(1), 43–50 (2014)
Stang, A., Jöckel, K.-H.: Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Cancer 122(3), 432–437 (2016)
Katalinic, A., Eisemann, N., Waldmann, A.: Skin cancer screening in Germany—documenting melanoma incidence and mortality from 2008 to 2013. Dtsch Arztebl Int 112(38), 629–634 (2015)
Federman, D.G., Kirsner, R.S., Viola, K.V.: Skin cancer screening and primary prevention: facts and controversies. Clin. Dermatol. 31(6), 666–670 (2013)
Grossman, M.: On the concept of health capital and the demand for health. J Polit Econ 80(2), 223–255 (1972)
Little, E.G., Eide, M.J.: Update on the current state of melanoma incidence. Dermatol. Clin. 30(3), 355–361 (2012)
Conway, D.I., Brenner, D.R., McMahon, A.D., Macpherson, L.M., Agudo, A., Ahrens, W., Bosetti, C., Brenner, H., Castellsague, X., Chen, C., Curado, M.P., Curioni, O.A., Dal, M.L., Daudt, A.W., Edefonti, V., Fabianova, E., Fernandez, L., Franceschi, S., Gillison, M., Hayes, R.B., Healy, C.M., Herrero, R., Holcatova, I., Jayaprakash, V., Kelsey, K., Kjaerheim, K., Koifman, S., Vecchia, C., Lagiou, P., Lazarus, P., Levi, F., Lissowska, J., Luce, D., Macfarlane, T.V., Mates, D., Matos, E., McClean, M., Menvielle, G., Merletti, F., Morgenstern, H., Moysich, K., Muller, H., Muscat, J., Olshan, A.F., Purdue, M.P., Ramroth, H., Richiardi, L., Rudnai, P., Schantz, S., Schwartz, S.M., Shangina, O., Simonato, L., Smith, E., Stucker, I., Sturgis, E.M., Szeszenia-Dabrowska, N., Talamini, R., Thomson, P., Vaughan, T.L., Wei, Q., Winn, D.M., Wunsch-Filho, V., Yu, G.P., Zhang, Z.F., Zheng, T., Znaor, A., Boffetta, P., Chuang, S.C., Ghodrat, M., Amy, L.Y.C., Hashibe, M., Brennan, P.: Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case–control studies from 27 countries. Int. J. Cancer 136(5), 1125–1139 (2015)
Aarts, M.J., Lemmens, V.E., Louwman, M.W., Kunst, A.E., Coebergh, J.W.: Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur. J. Cancer 46(15), 2681–2695 (2010)
Eurostat: NUTS—nomenclature of territorial units for statistics. Overview (2016). http://ec.europa.eu/eurostat/web/nuts/overview. Accessed 4 May 2016
Angrist, J.D., Pischke, J.-S.: Mostly harmless econometrics. An empiricist’s companion. Princeton University Press, Princeton (2009)
Sabates, R., Feinstein, L.: The role of education in the uptake of preventative health care: the case of cervical screening in Britain. Soc. Sci. Med. 62(12), 2998–3010 (2006)
Wooldridge, J.M.: Introductory econometrics. A modern approach. South-Western Cengage Learning, Mason (2013)
Deb, P., Gallo, W.T., Ayyagari, P., Fletcher, J.M., Sindelar, J.L.: The effect of job loss on overweight and drinking. J Health Econ 30(2), 317–327 (2011)
Black, W.C., Haggstrom, D.A., Welch, H.G.: All-cause mortality in randomized trials of cancer screening. J. Natl Cancer Inst. 94(3), 167–173 (2002)
Welch, H.G., Black, W.C.: Overdiagnosis in cancer. J. Natl Cancer Inst. 102(9), 605–613 (2010)
Welch, H.G., Woloshin, S., Schwartz, L.M.: Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 331(7515), 481–484 (2005)
Carli, P., Mannone, F., de Giorgi, V., Nardini, P., Chiarugi, A., Giannotti, B.: The problem of false-positive diagnosis in melanoma screening: the impact of dermoscopy. Melanoma Res. 13(2), 179–182 (2003)
Losina, E., Walensky, R.P., Geller, A., Beddingfield, F.C., Wolf, L.L., Gilchrest, B.A., Freedberg, K.A.: Visual screening for malignant melanoma. A cost-effectiveness analysis. Arch. Dermatol. Res. 143(1), 21–28 (2007)